Related Experiment Video
Updated: Apr 9, 2026

Genome-wide Mapping of Drug-DNA Interactions in Cells with COSMIC Crosslinking of Small Molecules to Isolate Chromatin
Published on: January 20, 2016
Binding of topotecan to chromatin: Insights into cooperative binding and comparison with DNA
Masoome Babaei1, Azra Rabbani-Chadegani1, Parinaz Ghadam2
1Department of Biochemistry, Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.
Abstract:
Topotecan (TPT) is an anticancer drug widely used in cancer therapy. Although the interaction of TPT with DNA is a subject of few reports, no work has been reported on the binding affinity of TPT to DNA-histone complex in chromatin structure. In the present study we have focused on the effect of TPT on chromatin employing various types of spectroscopy and equilibrium dialysis techniques. The results showed that TPT quenched with chromatin chromophores and decreased fluorescence emission intensity corresponding to aromatic residues of histone proteins. The UV absorbance at 260 and 210 nm in decreased in a dose dependent manner. Upon binding of the drug, ellipticity at 222 nm in the circular dichroism profile became more positive implying reduction of α-helix content of histones. The binding is positive cooperative with association constant (Ka) of 2.65×10(2) M(-1) and 1.11×10(2) M(-1) for chromatin and DNA respectively indicating higher affinity of TPT to chromatin compared to DNA. From the results it is concluded that in the cell nucleus, TPT, as a potent anticancer drug, exerts its biological action through binding to chromatin and in this process not only DNA but also histone proteins play a fundamental role.
Insights
Topotecan (TPT), an anticancer drug, binds more strongly to chromatin than DNA. This interaction involves both DNA and histone proteins, influencing TPT's anticancer activity within the cell nucleus.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Therapeutics
Background:
- Topotecan (TPT) is a crucial anticancer agent.
- Limited research exists on TPT's interaction with DNA-histone complexes in chromatin.
Purpose of the Study:
- To investigate the binding affinity of Topotecan (TPT) to the DNA-histone complex within chromatin.
- To elucidate the role of chromatin structure in TPT's anticancer mechanism.
Main Methods:
- Utilized spectroscopy (UV-Vis, fluorescence, circular dichroism) and equilibrium dialysis.
- Analyzed TPT's effects on chromatin chromophores and histone protein structure.
- Quantified binding affinity using association constants.
Main Results:
- TPT binding decreased fluorescence intensity of histone aromatic residues and UV absorbance.
- Circular dichroism indicated a reduction in histone alpha-helix content upon TPT binding.
- TPT exhibited higher binding affinity to chromatin (Ka = 2.65×10^2 M⁻¹) than to DNA alone (Ka = 1.11×10^2 M⁻¹).
Conclusions:
- Topotecan interacts with both DNA and histone proteins in chromatin.
- Histone proteins play a significant role in Topotecan's biological action.
- TPT exerts its anticancer effects by binding to the overall chromatin structure.
More Related Videos
10:12Author Spotlight: Quantitative Detection of DNA Protein Crosslinks and Their Post-Translational Modifications
Published on: April 21, 2023
21:55Chromatin Interaction Analysis with Paired-End Tag Sequencing ChIA-PET for Mapping Chromatin Interactions and Understanding Transcription Regulation
Published on: April 30, 2012
Related Concept Videos
Cooperative Binding of Transcription Regulators
Cooperative Binding of Transcription Regulators
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. ...
Co-activators and Co-repressors
Chromatin Immunoprecipitation- ChIP
Types of ChIP
ChIP can be divided into two types - X-ChIP and N-ChIP. X-ChIP involves in vivo cross-linking of histones and regulatory proteins to DNA, fragmenting the DNA by sonication, and isolating the protein-DNA...
Single-Strand DNA Binding Proteins